Kalain Workman, DO
Adult Reconstructive Orthopaedic Surgery · Newport News, VANPI 1124470109
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,912 of the $11,619 with a category attached, or 68.1%. Smith+Nephew accounts for 67.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $5,181 and has fallen 95.0% since, to $259 in 2025.
Across 60 payments — averaging $193.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$8K
- Zimmer Biomet$2K
- Omnilife Science, Inc$568
- Stryker$521
- Medical Device Business Services, Inc.$346
- Johnson & Johnson$223
- plus $285 from 7 others
What the payments were for
- Travel & lodging$1,73115%
- Food & beverage$1,85616%
- Education$7,91268%
- Gifts$1201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $7,790 |
| Zimmer Biomet | 23 | $1,886 |
| Omnilife Science, Inc | 3 | $568 |
| Stryker | 11 | $521 |
| Medical Device Business Services, Inc. | 2 | $346 |
| Johnson & Johnson | 5 | $223 |
| Medtronic | 3 | $97 |
| Sanara Medtech Inc. | 2 | $80 |
| Microport Orthopedics Inc | 1 | $34 |
| Heraeus Medical, LLC. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Think Surgical, Inc. | 1 | $19 |
| Nextstep Arthropedix, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA$619
- OMNIBotics 3.0$504
- Persona$469
- INSIGNIA$168
- MAKO$168
- TRITANIUM$168
- mymobility Platform$128
- Engage Partial Knee System$120
- Avenir$117
- REAL INTELLIGENCE$117
- Journey II$117
- ATTUNE$108
- Velys$108
- ACTIS$108
How this compares
$11,619 in reported general payments places this provider in the 55th percentile of 58 adult reconstructive orthopaedic surgery providers in Virginia.
See all adult reconstructive orthopaedic surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate Pot ErAmoxicillin/Potassium Clav | 48 | $959 |
| Meloxicam | 278 | $583 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 82 | $470 |
| Cefadroxil | 55 | $354 |
| Ondansetron Hcl | 56 | $324 |
| Cephalexin | 51 | $291 |
| Tramadol Hcl | 77 | $231 |
| Methylprednisolone | 43 | $227 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $165 |
| Pantoprazole Sodium | 23 | $116 |
| Gabapentin | 25 | $94 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Newport News
- Anthony CarterNewport News$521K
- Nitin GoyalArlington$81.5M
- William HamiltonAlexandria$9.3M
- Charles EnghArlington$5.5M
- James BrowneCharlottesville$4.8M
- Kevin FrickaAlexandria$773K
- John CardeaRichmond$141K
- Andrew NeviaserMc Lean$136K
- Robert SershonArlington$94K
- Ian DuensingCharlottesville$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.